AIRNA
AIRNA, a biotech company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD371—556m (Dealroom.co estimates Jul 2024.)
Cambridge Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $30.0m | Early VC | |
* | $60.0m | Series A | |
| Total Funding | AUD139m | ||